CHEK1 and acute myeloid leukemia: Importantly, the sensitizing effects of CHK1 knockdown (Fig. 3a) or CHK1 inhibition (Figs 2, 3 and 4a–c) were often observed at drug concentrations that did not appreciably kill AML cell lines on their own.